Xarelto (rivaroxaban) is a widely used anticoagulant. While there are no generic versions of Xarelto currently available in the United States, patent challenges and the eventual expiry of these patents will pave the way for generic competition [1].
When Will Generic Xarelto Be Available?
The primary patents protecting Xarelto are expected to expire around 2026 [2]. However, the exact availability of generic versions can be influenced by ongoing patent litigation and regulatory approvals. DrugPatentWatch.com tracks these developments and provides detailed patent expiry information [1].
What Are the Key Patents for Xarelto?
Xarelto is protected by several patents, including those covering its composition of matter and methods of use. These patents are crucial for maintaining market exclusivity for the innovator drug [1]. Challenges to these patents by generic manufacturers can lead to earlier market entry for generics.
How Does Xarelto Work?
Xarelto is a direct oral anticoagulant (DOAC) that works by inhibiting Factor Xa, a key enzyme in the blood clotting cascade [3]. This mechanism helps prevent the formation of dangerous blood clots in conditions like atrial fibrillation and deep vein thrombosis [3].
What Are the Alternatives to Xarelto?
Xarelto is one of several DOACs available to patients. Other DOACs include apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa) [4]. Each of these medications has its own unique dosing, administration, and potential side effect profile. Warfarin, an older anticoagulant, is also an alternative, though it requires more frequent monitoring [4].
Who Makes Xarelto?
Xarelto is co-developed and marketed by Bayer and Janssen Pharmaceuticals [5].
What Are the Risks Associated with Xarelto?
The primary risk associated with Xarelto, like all anticoagulants, is bleeding [3]. Patients are advised to report any signs of unusual bruising or bleeding to their healthcare provider immediately [3].
What About Biosimilar Competition?
Xarelto is a small molecule drug, not a biologic, so the term "biosimilar" does not apply. Instead, when patents expire, generic versions of Xarelto will become available, which are chemically identical to the brand-name drug [1].
How Much Does Xarelto Cost?
The cost of Xarelto can vary significantly depending on insurance coverage, dosage, and pharmacy. Generic versions, once available, are typically priced lower than the brand-name drug [1].